Blood Work Abnormalities Indicating Acute Chest Syndrome in Sickle Cell Disease
The most important blood work abnormalities that indicate acute chest syndrome (ACS) in sickle cell disease include decreasing hemoglobin levels, elevated white blood cell count, and elevated inflammatory markers. 1
Key Laboratory Findings
Hematologic Abnormalities
- Decreasing hemoglobin values - a progressive drop in hemoglobin is one of the hallmark laboratory findings in ACS 1
- Thrombocytopenia - may be present in severe cases, especially when complications like thrombotic microangiopathy develop 2
- Elevated white blood cell count - indicates inflammatory response 1
- Presence of nucleated red blood cells - suggests increased erythropoiesis in response to hemolysis 2
- Evidence of hemolysis - including elevated lactate dehydrogenase (LDH) 2
Inflammatory Markers
- Elevated C-reactive protein (CRP) - indicates inflammatory response 3
- Elevated erythrocyte sedimentation rate (ESR) - suggests ongoing inflammation 3
- Elevated fibrinogen - part of the acute phase response 4
Biochemical Abnormalities
- Elevated lactate dehydrogenase (LDH) - indicates hemolysis and tissue damage 2
- Abnormal liver function tests - may be present due to hepatic involvement 3
- Elevated BUN/creatinine - may indicate renal involvement 4
Diagnostic Approach
Initial Laboratory Assessment
- Complete blood count (CBC) with differential - to evaluate for anemia, leukocytosis, and thrombocytopenia 4
- Comprehensive metabolic panel - to assess organ function 4
- Blood cultures - to identify potential infectious causes 1
- Arterial blood gas - to evaluate oxygenation status 5
Additional Testing Based on Clinical Presentation
- Serum typing and cross-matching - in preparation for potential transfusion therapy 1
- D-dimer and coagulation studies - to evaluate for thrombotic complications 3
- Cardiac biomarkers (troponin) - if cardiac involvement is suspected 4
Clinical Correlation
Interpreting Laboratory Results in Context
- Laboratory findings should be interpreted in conjunction with clinical symptoms (fever, respiratory symptoms) and radiographic evidence (new pulmonary infiltrate on chest X-ray) 3
- Serial monitoring of hemoglobin levels is crucial as a progressive decrease is characteristic of ACS 1
- Comparison with baseline values is important, especially for patients with chronic anemia 5
Monitoring Disease Progression
- Worsening anemia and increasing white blood cell count may indicate disease progression 1
- Development of thrombocytopenia may signal severe disease or complications 2
- Rising LDH levels correlate with increased hemolysis and tissue damage 2
Common Pitfalls in Laboratory Interpretation
- Failure to recognize that ACS can develop during hospitalization for other reasons (particularly pain crisis) - nearly half of ACS cases are diagnosed after admission for another reason 1
- Overlooking the significance of a progressive decrease in hemoglobin, which is a key indicator of developing ACS 1
- Not distinguishing between baseline chronic anemia in sickle cell disease and the acute drop in hemoglobin characteristic of ACS 5
- Missing the diagnosis of fat embolism syndrome, which can be a cause of ACS and may have overlapping laboratory findings 1